SCHEMBL626102

SCHEMBL626102

CN(c1nn2ccnc2s1)C1CCC2(CC1)OCC(C)(C)CO2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626163 0.82 HSD11B1 (0.32) —
SCHEMBL2250793 0.81 DYRK1A (0.32) —
SCHEMBL626146 0.74 — —
SCHEMBL13152990 0.65 — —
SCHEMBL625461 0.64 FYN (0.33) —
SCHEMBL625010 0.62 HSD11B1 (0.35) —
SCHEMBL625009 0.60 HSD11B1 (0.31) —
SCHEMBL424469 0.58 KMT2A (0.43) —
SCHEMBL1059038 0.57 ASGR1 (0.39) —
SCHEMBL16770070 0.57 KDM4E (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020215-A1 AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2012-02-16 — — WO disclosed
Send feedback